Phase 3 Essential Hypertension Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A
Essential Hypertension
Chong Kun Dang Pharmaceutical324 enrolled1 locationNCT06643819
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B
Essential Hypertension
Addpharma Inc.251 enrolled1 locationNCT06441630
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy
Essential HypertensionType 2 Diabetes Mellitus
Boryung Pharmaceutical Co., Ltd276 enrolled2 locationsNCT06220773
Recruiting
Phase 3
Efficacy and Safety of AJU-C52 in Essential Hypertension Patients
Essential Hypertension
AJU Pharm Co., Ltd.190 enrolled1 locationNCT06416865